Express Healthcare
Home  »  News  »  Neeraj Bhargava joins MedGenome Board of Directors

Neeraj Bhargava joins MedGenome Board of Directors

0 118
Read Article

Bhargava has a stellar career behind him that includes taking companies from launch to unicorn status

MedGenome, a genomics and clinical data driven diagnostics and drug discovery research company, announced that Neeraj Bhargava has joined their Board of Directors.

Bhargava, an alumnus of St Stephens, Delhi, Founder, CEO and Senior Managing Director of Zodius Capital Advisors. Zodius is an early investor in MedGenome. Neeraj is passionate about building market-defining companies across industries that challenge the status-quo.

Bhargava has a stellar career behind him that includes taking companies from launch to unicorn status. Prior to joining Zodius, he had co-founded and led multiple companies including WNS Global Services and e-Ventures India. Currently, Bhargava is an investor-operator and a board member at companies like BigBasket, Allygrow and Markets and Markets. Bhargava is also the CEO and Chairman of Rainshine Entertainment, a next-generation media and entertainment company.

“Bhargava’s unique combination of entrepreneurial, consulting and operational experience, coupled with his unparalleled network across the globe, makes him an ideal mentor for MedGenome” said Sam Santhosh Founder and Chairman of MedGenome. “Genomics is set to redefine the way healthcare is accessed and delivered today. We look forward to Bhargava’s guidance as we embark on the next phase of our growth. ”

“Genomics is an industry of the future and MedGenome is already a leader in the field. I am most impressed by MedGenome’s team and their scientific approach. I look forward to working closely with them to drive their next phase of growth,” said Bhargava.

Earlier in his career, Bhargava was a partner at McKinsey and Company, where he worked at New York, London and Mumbai offices and led practices and client relationships in the technology sector.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Want to know more about "Omic's" and it's relevance?
Register Now